erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
"the treatment of our family and the behaviour of the western trust has been disgraceful, they should be ashamed of themselves.
.